[The insulin, C-peptide and glucagon content of the blood of patients with chronic opisthorchiasis]. 1990

A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva

Insulin, C-peptide and glucagon levels were measured by radioimmunoassay in the blood of 42 patients with chronic opisthorchiasis and 27 healthy subjects. An insignificant decrease in insulin levels and a drastic decrease in C-peptide and glucagon levels have been established.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009889 Opisthorchiasis Infection with flukes of the genus Opisthorchis. Opisthorchis Infection,Opisthorchis felineus Infection,Opisthorchis viverrini Infection,Infection, Opisthorchis,Infection, Opisthorchis felineus,Infection, Opisthorchis viverrini,Infections, Opisthorchis,Infections, Opisthorchis felineus,Infections, Opisthorchis viverrini,Opisthorchiases,Opisthorchis Infections,Opisthorchis felineus Infections,Opisthorchis viverrini Infections
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
January 1983, Problemy endokrinologii,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
August 1978, Pediatriia,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
March 1981, Diabete & metabolisme,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
October 1979, Voprosy okhrany materinstva i detstva,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
May 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
October 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
September 1983, Anales espanoles de pediatria,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
January 1992, Voprosy pitaniia,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
January 2001, Clinical hemorheology and microcirculation,
A V Lepekhin, and S G Milevskaia, and V P Kiselev, and T F Stepanova, and L A Ruzaeva
January 1980, Sovetskaia meditsina,
Copied contents to your clipboard!